During the past decade, Osama Abdalmageed conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Osama Abdalmageed" are "In Vitro Fertilization" (2 trials), "Male Factor Infertility" (1 trials), "Pituitary Downregulation" (1 trials), "Placenta Accreta" (1 trials) and "Placenta Previa" (1 trials). Many other conditions were trialed in "Osama Abdalmageed" in a lesser frequency.

Most popular intervention types in "Osama Abdalmageed" are "Drug" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Ca Ionophore A23187" (1 trials), "Management of placenta accreta spectrum" (1 trials), "Melatonin" (1 trials) and "Omit Citrotide 0.25 dose on the day of triggering of ovulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Osama Abdalmageed" are 5 trials for "Female" genders.

Currently, there are NaN active trials in "Osama Abdalmageed". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Osama Abdalmageed, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Osama Abdalmageed, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".